Immune signatures associated with improved progression-free and overall survival for myeloma patients treated with AHSCT.
Ho CM, McCarthy PL, Wallace PK, Zhang Y, Fora A, Mellors P, Tario JD, McCarthy BLS, Chen GL, Holstein SA, Balderman SR, Cao X, Paiva B, Hahn T.
Ho CM, et al. Among authors: zhang y.
Blood Adv. 2017 Jun 20;1(15):1056-1066. doi: 10.1182/bloodadvances.2017005447. eCollection 2017 Jun 27.
Blood Adv. 2017.
PMID: 29296748
Free PMC article.